Skip to main content

Table 1 Clinical characteristics of the patients

From: Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma

 

Liver disease (n = 176)

HCC (n = 369)

P value

Age (y)

46.34 ± 11.71

56.91 ± 10.04

< 0.001

Gender (M/F)

124/52

318/51

< 0.001

Neutrophils (× 109/L)

5.705 (2.97–58.20)

0.674 (0.57–0.78)

< 0.001

Lymphocytes (× 109/L)

3.01 (1.65–30.85)

0.209 (0.12–0.295)

< 0.001

NLR

1.851 (1.43–2.53)

3.23 (1.91–6.62)

< 0.001

ALT (IU/mL)

38.5 (26.00–66.50)

38.9 (23.75–73.93)

0.739

AST (IU/mL)

29 (21.00–52.00)

44 (29.78–85.65)

< 0.001

AFP (ng/mL)

3.67 (2.43–10.36)

41.16 (5.59–1030.03)

< 0.001

  1. HCC, hepatocellular carcinoma; M, male; F, female; NLR, neutrophil-granulocyte ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AFP, alpha-fetoprotein
  2. Data are presented as mean ± standard derivation for age, actual values for gender, and median (interquartile range, Q25-Q75) for other parameters
  3. Comparisons between two groups were performed using t test for age, chi-square test for gender, or Wilcoxon test for other parameters